National Action Plan Receives Crucial Funding

Italy is poised to significantly bolster its fight against antimicrobial resistance (AMR) with a dedicated €120 million investment. The National Plan to Combat antimicrobial Resistance (PNCAR) is currently under discussion at the State Regions Conference, focusing on the allocation of funds for the period 2023-2025.

Strategic Allocation of Resources

The State Regions Conference is convening to finalize the agreement outlined in the 2022 Budget Law, which details the implementation of measures and interventions defined by the PNCAR (2022-2025). A key objective is to establish clear criteria for distributing the allocated €120 million over three years, alongside a robust system for monitoring the effectiveness of implemented activities.

Financial Backing for a National Priority

The financial maneuver of 2022 earmarked €40 million annually for 2023, 2024, and 2025 to support the PNCAR. These resources will be drawn from the national health plan budget, specifically those funds designated for objectives deemed of “priority” and “national importance.” This underscores the government’s commitment to tackling the growing threat of AMR.

The Urgency of Addressing AMR

The rise of antimicrobial resistance poses a significant threat to global health. According to a 2019 report by the CDC, more than 2.8 million antibiotic-resistant infections occur in the U.S. each year, and more than 35,000 people die as an inevitable result. Similar trends are observed worldwide, highlighting the urgent need for extensive action plans like Italy’s PNCAR.

Antimicrobial resistance is a global health security threat that requires urgent action across all sectors.

World Health Organization

Looking Ahead: Monitoring and Evaluation

The success of the PNCAR hinges not only on the allocation of funds but also on the rigorous monitoring and evaluation of its impact. Establishing clear metrics and obvious reporting mechanisms will be crucial to ensure that the allocated resources are used effectively and that the plan achieves its intended goals in combating antimicrobial resistance across Italy.